190 related articles for article (PubMed ID: 37058945)
21. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
Miao J; Chen S; Cao H; Ding Z; Li Y; Wang W; Nundlall K; Deng Y; Li J
Mol Carcinog; 2024 Jun; 63(6):1133-1145. PubMed ID: 38426797
[TBL] [Abstract][Full Text] [Related]
22. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells.
Yun HM; Park KR; Quang TH; Oh H; Hong JT; Kim YC; Kim EC
Arch Pharm Res; 2017 May; 40(5):601-609. PubMed ID: 28386742
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
[TBL] [Abstract][Full Text] [Related]
24. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
25. TRIM59 promotes osteosarcoma progression via activation of STAT3.
Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
[TBL] [Abstract][Full Text] [Related]
26. Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells.
Chen WT; Tsai YH; Tan P; Hsu FT; Wang HD; Lin WC; Lin FH; Wu CT
Anticancer Res; 2023 Mar; 43(3):1193-1199. PubMed ID: 36854535
[TBL] [Abstract][Full Text] [Related]
27. Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling.
Chen L; Feng D; Qian Y; Cheng X; Song H; Qian Y; Zhang X; Wu Y; Lv H; Liu Q; Cheng G; Yang B; Gu M
Phytomedicine; 2021 May; 85():153537. PubMed ID: 33744595
[TBL] [Abstract][Full Text] [Related]
28. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
Gao D; Jin N; Fu Y; Zhu Y; Wang Y; Wang T; Chen Y; Zhang M; Xiao Q; Huang M; Li Y
Eur J Med Chem; 2021 Apr; 216():113333. PubMed ID: 33689932
[TBL] [Abstract][Full Text] [Related]
29. Sinomenine prevents metastasis of human osteosarcoma cells via S phase arrest and suppression of tumor-related neovascularization and osteolysis through the CXCR4-STAT3 pathway.
Xie T; Ren HY; Lin HQ; Mao JP; Zhu T; Wang SD; Ye ZM
Int J Oncol; 2016 May; 48(5):2098-112. PubMed ID: 26983669
[TBL] [Abstract][Full Text] [Related]
30. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
Li ZZ; Wang YL; Yu YH; Xing YL; Ji XF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):105-112. PubMed ID: 30657552
[TBL] [Abstract][Full Text] [Related]
31. Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.
Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Lin B; Wang H; Zou D; Zhou Z; Xu J; Yi C; Cai Z
Cell Death Dis; 2016 Oct; 7(10):e2421. PubMed ID: 27735939
[TBL] [Abstract][Full Text] [Related]
32. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
[TBL] [Abstract][Full Text] [Related]
33. Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK/p38 MAPK-signaling pathway in human osteosarcoma cell lines.
Kang HM; Park BS; Kang HK; Park HR; Yu SB; Kim IR
Environ Toxicol; 2018 Jun; 33(6):640-649. PubMed ID: 29451351
[TBL] [Abstract][Full Text] [Related]
34. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
Liu B; Xu L; Dai EN; Tian JX; Li JM
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
[TBL] [Abstract][Full Text] [Related]
36. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
37. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
38. Pectolinarigenin acts as a potential anti-osteosarcoma agent via mediating SHP-1/JAK2/STAT3 signaling.
Zhang T; Li S; Li J; Yin F; Hua Y; Wang Z; Wang H; Zuo D; Xu J; Cai Z
Biomed Pharmacother; 2022 Sep; 153():113323. PubMed ID: 35752008
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
40. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
